Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2024 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. - Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. - Additional drug monographs are provided on the Evolve website. - Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. - Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. - Dosage and dilution charts within monographs provide quick summaries of essential clinical information. - Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. - Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds. - Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks. - NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information. - NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications. - NEW! Information on preparation and administration of injectable drugs from the National Coalition for IV Push Safety
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. - Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. - Additional drug monographs are provided on the Evolve website. - Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. - Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. - Dosage and dilution charts within monographs provide quick summaries of essential clinical information. - Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. - Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds. - Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks. - NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information. - NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications. - NEW! Information on preparation and administration of injectable drugs from the National Coalition for IV Push Safety
Table of Contents
Evolve website information General Dilution Charts How to Use This Book Preface Format and Content of Intravenous Medications Key to Abbreviations Important IV Therapy Facts Resources Preparation and Administration of Injectable Drugs IV Drugs Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs Appendix B: FDA Pregnancy Categories Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Appendix D: Information for Patients Receiving Immunosuppressive Agents Appendix E: Recently Approved Drugs Index
